🔗 Share this article

An underground market for unlicensed slimming drugs is being driven by TikTok fitness influencers and vendors on messaging platforms, according to new investigations.

Experimental Treatment Acquiring Popularity Via Social Media

The experimental drug, which remains in research studies, is being advertised by online personalities for its alleged weight-reducing effects. Viewers are encouraged to message these accounts directly for supplier links, while also obtaining discount codes.

Thriving Trade on Messaging Platforms

Additionally, a robust trade exists on Telegram, where communities with thousands of participants share comparison photos, administration instructions and claims of next-day British shipping. Sellers promote the drug there before redirecting buyers to other platforms for transactions.

Understanding The Experimental Drug

This medication is an investigational injection created by US drugmaker Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, GIP and glucagon. Preliminary studies suggest it could assist individuals reduce up to a quarter of their total weight. Referred to as the “triple G”, the substance is being hailed digitally as the successor to Ozempic.

Medical Professionals Voice Concerns

However, physicians and chemists have warned that the sale of what is still an unapproved drug in the UK is a cause for concern and could result in individuals injecting products of uncertain source.

Several experts stated the popularity for retatrutide could be connected to the rising price of approved weight loss treatments such as Mounjaro.

Regulatory Position and Enforcement

Selling the unapproved drug on social media or Telegram is prohibited in the UK, as it is an unapproved medication that cannot be marketed or supplied for human use under the British medical regulations.

Several content creators attempt to sidestep the rules by referring to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted substance, but advertising and distribution can still breach medicines, marketing, and consumer laws, potentially leading to penalties, legal action or imprisonment.

Platform Response and Content Elimination

Based on the social media company, the service has removed problematic material and prohibited related keywords and search suggestions. The organization stated it was committed to maintaining the platform secure and allocating resources in enhancing compliance measures.

Online Marketplace Activities

Investigations also discovered groups with up to nine thousand members selling retatrutide using Telegram's built-in discovery tool, which functions like a public directory. Entering “retatrutide” instantly displays groups with thousands of users, filled with images of slimming results, glowing reviews and detailed instructions for mixing or administering at home.

After moments of joining one group, a vendor posted contact information, where most transactions take place. The seller sent an guidebook and guaranteed shipping within 48 hours. When questioned whether the substance was authentic, one vendor said: “You can’t be sure.” Another provided a image of a alleged testing documentation. Not one asked about weight, medical conditions or past usage.

Product Details and Pricing

Inside these groups, posts show dark colored packages with postal service stickers, claiming to include fresh supplies. One message read: “It took eight of us to load them this morning.”

Customers can choose between powder vials, mixed at residence with sterile water, or pre-filled injectors usually priced at £160 for 20 milligrams. When questioned how much time a pen should be used, vendors give conflicting responses ranging from a several days to “depends on your body”.

Service Moderation and Security Actions

A spokesperson for Telegram stated it regularly moderated dangerous content on its service including content that promoted the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“People are injecting substances they can’t verify. Although the science behind this drug is valid, these online versions may not contain what they advertise,” said a pharmacy expert, the head of pharmacy at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor connected the surge in demand to recent price rises for authorized weight-loss medications such as Mounjaro. “With costs rising, individuals are using online platforms. But fake injections are highly risky. You can’t be certain what’s inside or whether the environment they were produced in was sterile,” she explained.

Her staff has already encountered patients injured by personal administration from unconfirmed suppliers. “We understand the disappointment, but buying from Telegram or WhatsApp is gambling with your well-being,” stated the doctor. “These materials could be contaminated or incorrectly dosed.”

Manufacturer Statement

A spokesperson from the pharmaceutical company said the substance was in phase 3 clinical trials and had not been reviewed or approved by any government authority globally. “Therefore at this time no one can sell [it] for human use,” they said, adding that any item “misleadingly claiming itself as a Lilly investigational product not yet authorized … may subject patients to possibly serious health risks”.